Yale Faculty to Direct PTSD Study 10/03/2005

Discussion in 'General Medical' started by rainvet, Oct 4, 2005.

  1. rainvet

    rainvet New Member

    Likes Received:
    2
    Trophy Points:
    0
    Yale Faculty to Direct PTSD Study
    Business New Haven
    10/03/2005
    BNH
    NEW HAVEN - The Yale School of Medicine will direct a $6.9 million nationwide study into the effectiveness of an anti-psychotic medication, risperidone, for veterans with chronic, military service-related post-traumatic stress disorder (PTSD). Thirteen percent of all VA mental health costs, or $274 million, is spent to care for veterans with PTSD. Currently, there are only two medication treatments approved by the U.S. Food & Drug Administration for the treatment of PTSD.

    John Krystal, MD, professor in the Department of Psychiatry at Yale School of Medicine and Robert Rosenheck, MD, also a professor of psychiatry at Yale, will direct the study from the VA Connecticut Healthcare System in West Haven. As part of the study 400 veterans with chronic, military service-related PTSD will be enrolled at 20 VA hospitals from across the country over a two-year period.
  2. neumaiek

    neumaiek New Member

    Likes Received:
    0
    Trophy Points:
    0
    Frickin GREAT!! One of the most liberal havens of anti-war sentiment is going to help veterans?!?!? We are on our way to living on the street.

Share This Page